{"id":"allergovit","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["Allergovit, grass pollen 100%, Allergopharma, Germany"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:39:22.998Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04104828","phase":"","title":"Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2019-11-05","conditions":"Allergic Rhinitis","enrollment":24},{"nctId":"NCT02297490","phase":"PHASE2","title":"Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials","status":"TERMINATED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2014-01","conditions":"Allergic Rhinoconjunctivitis, Healthy Volunteers","enrollment":158},{"nctId":"NCT01431859","phase":"PHASE4","title":"Can we Help People With the Oral Allergy Syndrome Eat Fresh Fruit?","status":"UNKNOWN","sponsor":"Royal Sussex County Hospital","startDate":"2012-07","conditions":"Oral Allergy Syndrome","enrollment":40},{"nctId":"NCT00263627","phase":"PHASE3","title":"Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens","status":"COMPLETED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2005-06","conditions":"Pollen Allergy","enrollment":253},{"nctId":"NCT00263601","phase":"PHASE3","title":"Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2001-11","conditions":"Grass Pollen Allergy","enrollment":154},{"nctId":"NCT01523158","phase":"NA","title":"Mechanisms of Allergen Immunotherapy","status":"TERMINATED","sponsor":"Royal Sussex County Hospital","startDate":"2012-04","conditions":"Allergic Rhinitis","enrollment":2},{"nctId":"NCT01555736","phase":"PHASE4","title":"Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2003-01","conditions":"Seasonal Allergic Rhinitis","enrollment":120},{"nctId":"NCT01475188","phase":"PHASE4","title":"Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy","status":"COMPLETED","sponsor":"Ministry of Science and Higher Education, Poland","startDate":"2007-03","conditions":"Immunotherapy, Seasonal Allergic Rhinitis","enrollment":41}],"_emaApprovals":[],"_faersSignals":[{"count":5,"reaction":"BRADYCARDIA"},{"count":5,"reaction":"DECREASED APPETITE"},{"count":5,"reaction":"EMOTIONAL POVERTY"},{"count":5,"reaction":"FATIGUE"},{"count":5,"reaction":"HYPOTENSION"},{"count":5,"reaction":"NOCTURIA"},{"count":5,"reaction":"SEXUAL DYSFUNCTION"},{"count":5,"reaction":"VISUAL IMPAIRMENT"},{"count":5,"reaction":"WEIGHT DECREASED"},{"count":4,"reaction":"OFF LABEL USE"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":27,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Allergovit","genericName":"Allergovit","companyName":"University of Zurich","companyId":"university-of-zurich","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}